TrialEuropean journal of clinical pharmacology2023

Safety of SGLT2 inhibitors in patients with different glomerular diseases treated with immunosuppressive therapies.

Ahmed Elkeraie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.